Company Filing History:
Years Active: 2018-2024
Title: Pyoung Oh Yoon: Innovator in Fibrosis and Respiratory Disease Treatments
Introduction
Pyoung Oh Yoon is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical research, particularly in the development of treatments for fibrosis and respiratory diseases. With a total of three patents to his name, Yoon's work focuses on innovative therapeutic approaches that leverage advanced oligonucleotide technologies.
Latest Patents
Yoon's latest patents include groundbreaking inventions aimed at preventing and treating fibrosis-related diseases and respiratory diseases. One of his notable inventions is a double-stranded oligonucleotide that specifically inhibits amphiregulin expression. This invention includes a double-stranded oligonucleotide structure that can be combined with nanoparticles for effective delivery. Another significant patent involves a novel siRNA and a high-efficiency double-stranded oligo RNA structure designed for targeted treatment of fibrosis and respiratory diseases. This structure is engineered for efficient cellular delivery and includes a pharmaceutical composition as an active ingredient.
Career Highlights
Throughout his career, Pyoung Oh Yoon has worked with prominent companies in the biotechnology sector, including Bioneer Corporation and Yuhan Corporation. His experience in these organizations has allowed him to refine his expertise in developing innovative medical solutions.
Collaborations
Yoon has collaborated with several professionals in his field, including Youngho Ko and Han Oh Park. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Pyoung Oh Yoon is a distinguished inventor whose work in the field of fibrosis and respiratory disease treatments has the potential to make a significant impact on healthcare. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.